Cerca | Friends - Best Social Network - החברים

Kan Kumar ha aggiunto una foto Altre informazioni
2025-07-02 12:30:31

Opportunities and Challenges in the Duchenne Muscular Dystrophy Therapeutics Market
Duchenne Muscular Dystrophy constitutes the most prevalent childhood muscular dystrophy, affecting approximately one in 3,500 male births globally. This devastating X-linked disorder results from dystrophin gene mutations that prevent normal muscle fiber maintenance, leading to progressive weakness, mobility loss, and premature mortality from cardiopulmonary complications. Recent therapeutic...

0 Commenti 0 condivisioni 103 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Devidi Jahnavi ha aggiunto una foto Health
2025-06-17 07:02:31

The Role of CRISPR and AAV in Duchenne Gene Repair
Duchenne Muscular Dystrophy (DMD) is a rare, progressive neuromuscular disorder that leads to severe muscle degeneration and early mortality. Affecting roughly 1 in 3,500 to 5,000 male births globally, DMD stems from mutations in the DMD gene, which encodes dystrophin, a protein critical for muscle fiber integrity. Without dystrophin, muscle cells become fragile and eventually die, leading to...

0 Commenti 0 condivisioni 269 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Uttej Netha ha aggiunto una foto Health
2025-07-01 04:53:54

High Therapy Costs Remain Barrier Despite Market Growth to USD 8.84B
The North America Duchenne Muscular Dystrophy (DMD) Treatment Market is set for significant growth, expanding from USD 2.06 billion in 2024 to USD 8.84 billion by 2033, at an impressive compound annual growth rate (CAGR) of 20.2% during the period 2025–2033. Download Sample Report:...

0 Commenti 0 condivisioni 250 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!